Sign in
Taking people in United StatesNo phase

Whey protein and blood sugar in people with prediabetes or type 2 diabetes

Tests whey protein drinks against placebo for blood sugar in adults with prediabetes.

Key facts

Who runs it
University of Arkansas
Where
Little Rock, United StatesSee the site
Trial code
Registry title
Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals
Status
Recruiting
People taking part
40 people, planned
Started
15 Jan 2025
Expected to end
1 Mar 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Whey Protein Isolate Crossover
  • Placebo
Record updated
6 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 50 to 70 with prediabetes or type 2 diabetes. It tests whey protein taken twice a day and its effect on blood sugar and insulin.

Age
50 to 70 years
Sex
Men and women
Disease stage
Prediabetes or diabetes: HbA1c 5.7-6.4% (39–46 mmol/mol) or 6.5% to 7.5%, or fasting glucose of 100 mg/dL (5.6 mmol/L) or more. Body mass index 25-45 kg/m2.
Earlier treatment
People cannot join if they take insulin injections, GLP/GIP injections or other appetite suppressants, or take androgen, anabolic or corticosteroid medicines.
Biomarker or test result
HbA1c 5.7-6.4% (39–46 mmol/mol) or 6.5% to 7.5%, or fasting glucose of 100 mg/dL (5.6 mmol/L) or more. COVID-19 negative and/or without symptoms.

Main reasons for not taking part

  • Does not eat dairy protein, or has lactose intolerance
  • Takes insulin or GLP/GIP injections or appetite suppressants
  • Pregnant or breastfeeding
  • Had stomach or bowel bypass or reduction surgery
  • Has a long-lasting inflammatory disease such as lupus or Crohn's disease

The registry criteria, word for word

Show all 21 criteriaShow less

Who can take part

  • Males and females ages 50-70 years
  • Body mass index between 25-45 kg/m2
  • Capable of providing informed consent
  • COVID-19 negative and/or asymptomatic
  • Willing to abstain from drinking alcohol or consuming marijuana and CBD products during the 7-day study meal period on two occasions
  • HbA1c: 5.7-6.4% or 6.5% to 7.5% or fasting glucose ≥100 mg/dL

Who cannot take part

  • History of chemotherapy or radiation therapy for cancer in the 6 months prior to enrollment
  • Currently receiving androgen (e.g., testosterone) or anabolic (e.g., GH, IGF-I) therapy
  • Currently using corticosteroid medications (cortisone, hydrocortisone, prednisone, etc.)
  • History of gastrointestinal bypass/reduction surgery
  • History of a chronic inflammatory disease (e.g. Lupus, Crohn's disease)
  • Any medical condition or medication that the PI or clinical study staff finds contradictory to this study
  • Hemoglobin <10g/dL at screening
  • Subject who does not/will not eat dairy protein sources
  • Subjects taking exogenous insulin injections or GLP /GIP injections or other appetite suppressants
  • Unwilling to keep a detailed 7 day food journal on two occasions
  • Unwilling to wear a CGM for 7 days on two occasions and share the data with the research team
  • Lactose intolerance
  • Pregnant or lactating individuals
  • Unwilling to avoid using protein or amino-acid supplements during participation
  • Unwilling to fast overnight

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 50 and 70 years old?

Where in United States

  • University of Arkansas for Medical SciencesLittle Rock, United StatesContact: Samantha Seale, MSTaking people

About the trial

What the trial wants to find out

To examine the effects of twice daily whey protein consumption on blood glucose and insulin in pre-diabetic and diabetic individuals

The 2 groups in the trial

  • Whey Protein SupplementationTreatment being tested

    Crossover study

    Treatment: Whey Protein Isolate Crossover

  • Placebo SupplementationPlacebo, for comparison

    Crossover study

    Treatment: Placebo

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals
Plain-language title
Whey protein and blood sugar in people with prediabetes or type 2 diabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06694155, who can take part
Record updated
6 April 2026